The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...

Not taking enough vitamin D can cause more harm than you’ve heard. Take the risk to heart health, for example. But no worries ...

The observational study conducted by Albert and colleagues assessed 43,625 patients hospitalized with heart failure in the 241 hospitals participating in the Get With The Guidelines–Heart Failure ...

The phase 2 EXPLORE-CKD trial is examining the efficacy and safety of lorundrostat in addition to SGLT2 inhibitors in patients with hypertension and CKD with albuminuria.

A newly developed drug has been found to offer 24 hour protection from high blood pressure, including early mornings when the ...

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins ...

Cancer treatments can exert cardiotoxic effects, but screening and monitoring can detect and minimize cancer therapy-related ...

These findings for lorundrostat will provide the foundation for an NDA submission which we anticipate submitting near the end of 2025 or during the first quarter of 2026,” stated Jon Congleton, Chief ...

A new treatment for high blood pressure can provide continuous, round-the-clock blood pressure control for people whose ...

Discover the complexities of Addison's disease in dogs, including diagnosis, treatment options, and management strategies for ...

CKD prevalence has more than doubled since 1990, with 788 million adults affected in 2023, highlighting a significant global health challenge. The disease is a major contributor to cardiovascular ...

Balcinrenone is similar to finerenone (Kerendia), which is also a nonsteroidal MRA and was approved for the slowing of ...